Kiniksa Pharmaceuticals International earnings were -$9.1M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest KNSA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$12.7M, up 224.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, KNSA reported annual earnings of $14.1M, with -92.3% growth.
Kiniksa Pharmaceuticals International Earnings Reports & History FAQ
What were Kiniksa Pharmaceuticals International's earnings last quarter?
Kiniksa Pharmaceuticals International (NASDAQ: KNSA) reported Q3 2024 earnings per share (EPS) of -$0.18, up 10% year over year. Total KNSA earnings for the quarter were -$12.69 million. In the same quarter last year, Kiniksa Pharmaceuticals International's earnings per share (EPS) was -$0.20.
Is Kiniksa Pharmaceuticals International profitable or losing money?
As of the last Kiniksa Pharmaceuticals International earnings report, Kiniksa Pharmaceuticals International is currently losing money. Kiniksa Pharmaceuticals International's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$9.07 million, a 35.51% increase year over year.
What was KNSA's earnings growth in the past year?
As of Kiniksa Pharmaceuticals International's earnings date in Q4 2024, Kiniksa Pharmaceuticals International's earnings has grown year over year. KNSA earnings in the past year totalled -$9.07 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.